Mediar Therapeutics has dosed the first subject in the Phase II WISPer trial of its investigational therapy, MTX-463, for IPF ...

A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and ...

Understand why menopause causes bone density loss in women. Learn the hormonal changes responsible and effective strategies ...

Discover how magnesium deficiency affects 45% of Americans, causing symptoms from irregular heartbeats to sleep issues, plus ...

Toss in beans: Black beans, edamame and kidney beans are all good sources of magnesium. Snack on some Edamame with Aleppo ...

where calcium imbalance and impaired synaptic signaling are key features. This newly identified GPR158–PLCXD2 axis offers insight into how synaptic structure and receptor content are regulated ...

Yale researchers are providing new insights into how physical forces, such as cells being compressed in physically ...

Engineering of TRPM8 channel to be activated by CHXOL and more sensitive to CHXOL.  FAYETTEVILLE, GA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- In a breakthrough advancement for neuroscience, ...

The market for hypercalcemia treatment is expected to reach approximately USD 22,640.2 million in 2025 and expand to around USD 52,303.9 million by 2035, reflecting a compound annual growth rate (CAGR ...

BioPrime develops biologicals that help crops manage abiotic stressors such as heat and drought, and improve resistance to ...